left central scotoma. The optic nerves were of normal size and colour with dilated capillaries on both discs which did not show leakage on fluorescein angiography.
Investigations revealed a normal blood count, biochemical screen, clotting studies and ESR. In addition antibody screen for rheumatoid factor, and anti-nuclear factor were negative, as was syphilis serology.
Cerebrospinal fluid examination at lumbar puncture revealed an opening pressure of 180 mm water with a cerebrospinal fluid white count less than 1 million, protein 0.2 gil, with no oligoclonal bands. Nuclear magnetic resonance scanning using STIR sequences, detected an increased signal in the left optic nerve. The right optic nerve signal was normal and no other lesions were seen.
Discussion
As far as we are aware the case reported here represents the first description of an association between Leber's optic neuropathy and mitral valve prolapse. The cardiovascular abnormalities recently described in affected families with Leber's disease include; ECG abnormalities in the offspring of the female carriers, which may be unassociated with ocular pathology". Indeed cardiovascular symptoms, usually palpitations, were originally reported by Leber in 1871 6 • In the largest study of this type", 51% of a total of 79 individuals from descending female lines in four affected families displayed ECG abnormalities which included: pre-excitation syndromes (Wolff-Parkinson-White and Lown-Ganong-Levine); deep Q waves and unusually tall R waves in leads V4-V6: non-specific ST segment changes: right bundle branch block and voltage criteria of left and right ventricular hypertrophy: atrial fibrillation. Most subjects were asymptomatic, but echocardiography which was performed in 11 of the individuals, suggested in some cases the presence of cardiomyopathy", The patient
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Viral infections transmitted by blood transfusion
Keywords: virus; blood products; blood transfusion
Dr John Barbara (North London Blood Transfusion Service) described the typical blood transmitted virus as one where an inapparent carrier state was established, where the virus was stable in blood and where a long incubation period was often found. Most diagnostic methods were based on the detection of past infection through IgG antibodies rather than the detection of antigen itself; hepatitis B surface antigen is the exception rather than the rule. He noted that many of these infections are sexually transmitted and therefore encouragement of self-exclusion by donors in risk categories is recommended.
Dr Barbara identified four main problems from the blood transfusion standpoint: (l) The need for rapid release of blood products for patient therapy means that sensitive and specific assays are required which must also be simple and fast.
(2) Since plasma donations are pooled for fractionation in up to 20 000 units, one infected contribution could contaminate a whole pool. described here had some of the ECG abnormalities previously described, including the voltage criteria for left ventricular hypertrophy. The case is unique in that echocardiography did not confirm this ECG abnormality, but showed mitral valve prolapse confirmed on cardiac angiography. Furthermore no evidence was found of optic neuropathy on initial presentation, when his complaints were entirely cardiological.
We conclude that mitral value prolapse may be associated with Leber's optic atrophy. As mitral valve prolapse is associated with atrial dysrhythmias, it may be responsible for some of the dysrhythmias which occur in Leber's disease. Secondly, the ECG changes ofleft ventricular hypertrophy may not reflect true ventricular wall enlargement in these patients, as confirmed in this case by echocardiography and cardiac angiography. For these reasons we recommend that the patients with Leber's optic neuropathy and their asymptomatic relatives be submitted to echocardiography as well as routine ECG. (3) Clerical errors could be disastrous and so the development of computer transfer of individual donor data has been particularly useful.
(4) There is a need for long-term maintenance of lists of deferred donors to be kept in a confidential manner.
Dr S Cameron (University College and Middlesex
School of Medicine) reviewed hepatitis A, Band D and emphasized that hepatitis D virus infection could be prevented by immunization against hepatitis B.
Professor Howard Thomas (St Mary's Hospital
School of Medicine) emphasized that the clinical diagnosis of non-A non-B hepatitis required biochemical hepatitis, evidence of transmission (eg by blood transfusion) and exclusion of other agents known to cause hepatitis. Clinically, there appear to be three distinct groups although one or more viruses could cause one or more of these presentations. The parenterally acquired long incubation type (6-10 weeks) produces mild disease although 20-50% might develop chronic hepatitis, usually chronic persistent hepatitis but sometimes mild chronic active hepatitis. The parenteral short incubation type is especially associated with factor VIII concentrates and presents with fluctuating liver function tests and on biopsy reveals a lobular hepatitis progressing to chronic active hepatitis. This type had been transmitted to primates. The enterally transmitted epidemic type of non-A non-B hepatitis had an incubation period of 10-40 days and appears not to establish chronic infection. A virus which might be a picornavirus or calici virus has been associated with this condition.
Dr George Kuo (Chiron Corporation, Emeryville, California) then provided a scintillating description of how the Chiron biotechnology company had come to identify the virus which has been called hepatitis C virus (HCV). Nucleic acid sequences from blood samples of a chimpanzee infected with serum known to cause non-A non-B hepatitis were cloned into an expression library. Clones producing small protein products were identified by convalescent human serum from a non-A non-B hepatitis case followed by a radiolabelled antiserum. The clone contained a 155 base pair insert which was radiolabelled and used as a probe to react with the cDNA library. This identified a larger portion ofthe genome which could conveniently be used for southern and northern blotting. These experiments showed that messenger RNA from an infected chimp could be detected and that the signal was destroyed by RNAse but not by DNAse, showing that the virus contained RNA. Strand specific probes were then made which showed that the RNA contained a positive stranded genome of 5-10 kilobases. The genome was expressed as a fusion protein to allow Western blots to be performed with patient serum samples. This serological procedure identified coded samples known to be taken from non-A non-B hepatitis cases but not from controls. Likewise, serial samples from chimpanzees were shown to react in four out of four cases who had received factor VIII products. In all cases the antibody appeared in convalescence, showing that it would be necessary to demonstrate seroconversion in order to provide a diagnosis of hepatitis C infection.
Using overlapping clones of the genome, it was possible to identify one large open reading frame. This was expressed as a fusion protein and was shown to contain 363 amino acids of the virus antigen. Purity was better than 90% by SDS PAGE with a yield of 50%. This recombinant antigen will now be used in solid phase enzyme immunoassays to enable diagnostic laboratories to detect antibodies against HCV.
Antibodies against HCV were found in several parts of the world from documented cases of post transfusion non-A non-B hepatitis, sporadic non-A non-B hepatitis, haemophiliacs, cases of hepatocellular carcinoma, and also cases of autoimmune chronic active hepatitis. Whether these latter cases resulted from misdiagnosis by the referring physicians or could be explainable on the basis of false positive reactions given by the autoimmune sera remains to be defined. Studies of blood donors around the world show that approximately 1% of normal donors have antibody against HCV with about 10% of donors with raised ALTs being positive and 10% of those with antibodies against hepatitis B core antigen also having antibodies. Donors with both high ALT and anti-HBC have 50% positivity for anti-HCV.
Professor Paul Griffiths (Royal Free Hospital School of Medicine) summarized the evidence associating cytomegalovirus (CMV) and Epstein Barr virus with blood transfusion. Donations free of CMV could be identified by screening for CMV IgG antibodies but this was not particularly efficient since over 50% of the donor population was seropositive Journal of the Royal Society of Medicine Volume 83 January 1990 57 yet perhaps only 1% would actually be at risk of transmitting the virus. Nevertheless this clumsy approach could still protect particularly vulnerable individuals from CMV infection and these include fetuses in utero, pregnant women, premature neonates and immunocompromised patients. In an ideal world it would be highly desirable to increase the supply of CMV-free blood but this was impractical at the present time because ofthe high CMV seroprevalence and due to the difficulty of identifying individuals likely to transmit virus. Supplies were therefore only available for those in the highest risk groups, ie premature babies, pregnant women and CMV seronegative transplants.
Epstein Barr virus could definitely be transmitted by blood transfusion but this really occurred in only two situations both of which are rare. The first is when the donor lacks sufficient neutralizing antibody, for example during the incubation period of infectious mononucleosis or in an occasional individual who has not made sufficient quantities of neutralizing antibody. Secondly, it may occur when the recipient lacks neutralizing antibody and receives blood from a positive donor. Fortunately, most donors are antibody positive and so seronegative recipients would be passively immunized by receiving multiple blood transfusions.
Dr Bernard Cohen (Central Public Health Laboratory, Colindale) emphasized that blood from an acute case of parvovirus infection could contain up to 10 12 viruses per millilitre. This high virus concentration could explain why the virus can be rea~ily transmitted by factor VIII preparations.
Dr Myra McClure (North London Blood
Transfusion Centre) reviewed the biology of retroviruses emphasizing the unique aspects of the replication strategies of these important pathogens.
Dr Marcela Contreras and Dr John Barbara discussed the impact that HIV testing had had on the practice of blood transfusion. Some members of the public had become afraid of receiving blood even when it was prescribed for legitimate purposes by their medical attendants. This was leading to requests for designated donations and also for autologous transfusions. A few donors have become reluctant to donate blood due to the irrational concerns of contracting AIDS despite the fact that all of the equipment used in British Blood Transfusion Centres is sterile. Some donors are also concerned about being misclassified as being infected with HIV although this is very unlikely with the modern diagnostic methods available.
Testing for HIV P24 antigen did not seem to be helpful from the blood transfusion standpoint; over 750000 donors who were negative for antibody to HIV had been tested and all were shown to be antigen negative. Currently, about one donation in 100 000 is shown to contain antibody to HIV in Britain. As regards HIV 2, approximately 6500 donors known to have West African connections have been tested for antibody against this virus and no positives have been found.
Dr Richard Tedder (University College and Middlesex School of Medicine) emphasized the two archipelagos of Japan and Caribbean as being the major endemic sites for HTLV 1 infection. The virus was spread by breast feeding, by sexual contact and by contact with blood either through intravenous drug abuse or by transfusion. The lifetime risk for infected individuals of developing leukaemia was approximately 2% with a rather lower risk for developing myelopathy. Current assays for detecting anti HTLV 1 are of low specificity when used in low prevalence populations such as would be the case for UK donors. Though they are able also to detect anti-HTLV 2, many of the serum samples (>90%) giving positive reactions from UK donors have antibody profiles on Western Blot which suggest that the response is unrelated to exposure to HTLV. Before donor-screening is introduced in the UK, methods for confirmation and for differentiation between HTLV 1 and HTLV 2 infection will be needed especially if donor counselling of seropositives is to happen.
Finally, Dr Bruce Cuthbertson (Edinburgh) outlined the physical processes of plasma fractionation and showed that viruses tended to segregate in the albumin and cryoprecipitate fractions.
Albumin was rendered safe by pasteurization and a variety of different heating methods had been applied to factor VIII to inactivate HIV, and possibly other viruses, without destroying this delicate protein. These included heating in solution, heating freeze-dried powder, steam treatment of freeze-dried powder, treatment with iJ-propiolactone and ultraviolet light, extraction with lipid solvents and detergents, purification with monoclonal antibodies and hydrophobic adsorption chromatography. The relative merits of some of these procedures were discussed and the progress made towards eliminating viruses from blood products was described.
P D Griffiths M Contreras
Section of Pathology
Letters to the Editor
Review of medical audit
The otherwise excellent review by Dr McKee and colleagues (August 1989 JRSM, p474) should have been entitled 'medical audit in hospitals' as general practice is virtually ignored.
Primary medical care is more diverse and decentralized than hospital medicine, so audit has to be performed differently'. To consider the various types of assessment mentioned in the article, as applied in general practice:
(1) Case note review tends to be used as a tool for teaching and supervision in vocational training, and thus only indirectly for quality assessment.
Early postoperative feeding -a continuing controversy in pyloric stenosis I enjoyed the paper by Foster and Lewis (September 1989 JRSM, p 532) on early postoperative feeding following pyloromyotomy and I think this is a valuable contribution. The authors do, however, appear to confuse two issues; firstly, the question of whether there is any need to delay the first feed, and secondly, whether there is any need to reduce or gradually increase feeds thereafter. I have always believed that the traditional graded postoperative feeding regimens are unnecessary and I would agree entirely with their conclusion in this respect. However, with respect of the question as to whether it is better to delay feeds for 18 h postoperatively -perhaps a prospective controlled trial is the only way of answering this.
The main message of their paper, that it is unnecessary to withhold full feeds if the baby vomits postoperatively, is an important one and I hope that their recommendations on this will be widely accepted.
R D SPICER
Consultant Paediatric Surgeon The General Infirmary at Leeds
Registrar Consultant Physician Department of General Medicine
Central Middlesex Hospital London Hyperparathyroidism in a patient with myotonic dystrophy
We read with interest the report from Middleton, Posen and Shannon of a woman with hyperparathyroidism and myotonic dystrophy (April 1989 JRSM, p 227) . At the time we were investigating a similar case. A 56-year-old woman (CMH 269293) was admitted for investigation of poor balance and recurrent falls. She required bilateral cataract extraction aged 28, and was noted to have a peripheral pigmentary degeneration of the retina. Her mother also had bilateral cataracts. Examination showed muscle weakness, percussion myotonia and the typical facies of myotonic dystrophy, which was confirmed by electromyography. Hypercalcaemia was found on screening for endocrine disorder. Corrected serum calcium was 2.73 mmol/L, alkaline phosphatase 97 lUlL, creatinine 93 JtmollL. Immunoreactive parathormone, mixed terminal assay 0.18 pg/ml (normal < 0.5), midmolecule assay 1.5 pg/ml (normal < 1.0). Ultrasound of the neck did not demonstrate a parathyroid adenoma or hyperplasia. There were no symptoms directly attributable to hypercalcaemia, but the normal or high parathormone level in the presence of hypercalcaemia is strongly suggestive of hyperparathyroidism in this case.
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